Christopher J. Pinto

2.3k total citations
5 papers, 6 citations indexed

About

Christopher J. Pinto is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Christopher J. Pinto has authored 5 papers receiving a total of 6 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Cancer Research and 2 papers in Molecular Biology. Recurrent topics in Christopher J. Pinto's work include Cancer Genomics and Diagnostics (3 papers), Advanced Breast Cancer Therapies (2 papers) and Cancer Treatment and Pharmacology (2 papers). Christopher J. Pinto is often cited by papers focused on Cancer Genomics and Diagnostics (3 papers), Advanced Breast Cancer Therapies (2 papers) and Cancer Treatment and Pharmacology (2 papers). Christopher J. Pinto collaborates with scholars based in United States and China. Christopher J. Pinto's co-authors include Elizabeth O’Day, Dejan Juric, Bo Zhang, Jason Warner, Marielle Scherrer‐Crosbie, Daniel E. McLoughlin, Xinhui Wang, Raquel A. Jacobs, Christopher S. Chen and Wenjin Wu and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Frontiers in Oncology.

In The Last Decade

Christopher J. Pinto

4 papers receiving 6 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher J. Pinto United States	2	4	3	2	2	1	5	6
Nirmesh Patel United Kingdom	2	4 1.0×	3 1.0×		2 1.0×		3	7
Almat Kodasbayev Kazakhstan	2	4 1.0×	2 0.7×		3 1.5×		5	7
Jonathan Bermeo Australia	1	5 1.3×	3 1.0×		2 1.0×		2	8
Pedro Ferreira United Kingdom	2	4 1.0×	3 1.0×				4	5
P. Arumugam India	2	5 1.3×	3 1.0×				3	7
Z. Y. Ren China	3	5 1.3×	3 1.0×				7	12
Arthur E. Elghouayel United States	2	4 1.0×	4 1.3×				2	6
Costerwell Khyriem United Arab Emirates	2	3 0.8×	3 1.0×				3	5
Olga Kudryashova Russia	2	3 0.8×	3 1.0×				5	4
Nikita A. Verheyden Germany	2	3 0.8×	3 1.0×				3	4

Countries citing papers authored by Christopher J. Pinto

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Pinto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Pinto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Pinto more than expected).

Fields of papers citing papers by Christopher J. Pinto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Pinto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Pinto. The network helps show where Christopher J. Pinto may publish in the future.

Co-authorship network of co-authors of Christopher J. Pinto

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Pinto. A scholar is included among the top collaborators of Christopher J. Pinto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Pinto. Christopher J. Pinto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Jia, Lin, Steven J. Isakoff, Marielle Scherrer‐Crosbie, et al.. (2022). An Initial Evaluation of Human Plasma cMLC-1: A Potential Protein Biomarker for Trastuzumab-Induced Cardiotoxicity, Breast Cancer Screening and Progression. Frontiers in Oncology. 12. 809715–809715. 1 indexed citations

2.

Leshchiner, Elizaveta S., Ignaty Leshchiner, Elizabeth E. Martin, et al.. (2022). Abstract 1789: Chromatin modifier alterations confer resistance to endocrine deprivation and CDK4/6 inhibitors in ER+ breast cancer and drive convergent evolution in patient autopsy lesions. Cancer Research. 82(12_Supplement). 1789–1789.

3.

Leshchiner, Ignaty, Elizabeth E. Martin, Christopher T. Chen, et al.. (2021). Abstract 37: Convergence of resistance patterns in breast cancer after multiple lines of treatment through analysis of rapid autopsy samples. Cancer Research. 81(13_Supplement). 37–37. 1 indexed citations

4.

Utro, Filippo, Kahn Rhrissorrakrai, Chaya Levovitz, et al.. (2020). Abstract 1509: Estimation of lesion-specific mutation shedding in cfDNA from rapid autopsy study. Cancer Research. 80(16_Supplement). 1509–1509. 1 indexed citations

5.

Zhang, Bo, Jason Warner, Christopher J. Pinto, Dejan Juric, & Elizabeth O’Day. (2019). NMR-metabolite-resonance signature to predict HR+ breast cancer patient response to CDK4/6 inhibitors.. Journal of Clinical Oncology. 37(15_suppl). 3043–3043. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact